ArticleMedicine2026
Pre-frailty and frailty as predictors of mortality among colorectal cancer survivors: Evidence from the National Health Interview Survey (1997-2018).
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Frailty is a multidimensional syndrome associated with increased vulnerability to adverse health outcomes, particularly among older adults. Its relevance in cancer survivorship is increasingly recognized, yet the prognostic implications of frailty and pre-frailty among colorectal cancer survivors remain poorly defined. We conducted a prospective survival analysis using data from the 1997 to 2018 National Health Interview Survey, linked to mortality outcomes through December 31, 2019, via the National Death Index. Frailty status was determined using a modified fatigue, resistance, ambulation, illnesses, and low body mass index scale and categorized as robust (score = 0), pre-frail (score = 1-2), or frail (score = 3-5). Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause mortality by frailty status, adjusting for demographic, socioeconomic, and clinical variables. Subgroup analyses were conducted by age and sex. Among 4052 colorectal cancer survivors, 70.2% were robust, 12.4% pre-frail, and 17.4% frail. Frailty and pre-frailty were more prevalent among survivors than among cancer-free participants (6.5% frail; 5.0% pre-frail). In fully adjusted models, pre-frail and frail survivors had significantly higher risks of all-cause mortality compared to robust individuals (HR for pre-frail, 1.44; 95% confidence interval, 1.21-1.71; P < .001; HR for frail, 2.19; 95% confidence interval, 1.89-2.56; P < .001). These associations persisted across age and sex subgroups, although they were attenuated in younger adults and in men for pre-frailty. Kaplan-Meier curves demonstrated significantly reduced survival across increasing frailty categories. Frailty and pre-frailty are common among colorectal cancer survivors and are independently associated with increased risk of all-cause mortality. Frailty assessment may help identify vulnerable colorectal cancer survivors and inform risk stratification in survivorship care planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.